PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Mar-2023 Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences Sernova Corp.
02-Mar-2023 Pregis introduces AirSpeed Ascent high-pressure air cushioning system into the European marketplace Businesswire
02-Mar-2023 Clasado partners with Deimos Group in new distribution deal to bring Bimuno® GOS to the Italian market Clasado Biosciences
02-Mar-2023 Clasado expands its D2C prebiotic supplement range with Bimuno® Immunity launch Clasado Biosciences
02-Mar-2023 Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance Cherwell
02-Mar-2023 SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer SiSaf Ltd
02-Mar-2023 CMT Research Foundation (USA) collaborates with Augustine Therapeutics on new therapy against Charcot-Marie-Tooth disease Augustine Therapeutics
02-Mar-2023 Top Pharmaceutical and Life Science Events in March (2023) PharmiWeb.Jobs
02-Mar-2023 High Potency API Contract Manufacturing Value to reach US$ 8 Billion by 2032 | Oncology to account for over 60% Applications | FMI MARKITWIRED
02-Mar-2023 CD Genomics’ RNA-Solutions Platform Now Supports Exosomal RNA Research CD Genomics
02-Mar-2023 CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service CD Genomics
02-Mar-2023 LC-MS/MS Data Analysis Now Available Utilizing CD Genomics’ Bioinformatics-Analysis Solution CD Genomics
02-Mar-2023 Asklepios Kliniken: Group-wide ESG strategy Asklepios Kliniken
02-Mar-2023 Pedicle Screw Systems Market is expected to reach US$ 6.46 Billion by 2029 MARKITWIRED
02-Mar-2023 Loop-mediated Isothermal Amplification (LAMP) Market is expected to reach US$ 120.4 Million by 2028 MARKITWIRED
02-Mar-2023 Prurigo Nodularis Treatment Market is expected to reach US$ 86 Million by 2030 MARKITWIRED
02-Mar-2023 MorphoSys Stops Work and Operations on Pre-Clinical Research Programs MorphoSys AG
02-Mar-2023 Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIO™ to redefine expectations for treatment of children <12 years of age with hemophilia A Sanofi
02-Mar-2023 Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters MorphoSys AG
02-Mar-2023 Santhera Submits Marketing Authorization Application to the UK MHRA for Vamorolone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals